---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-26-018874"
form_type: "8-K"
ticker: "KTTA"
cik: "0001841330"
company_name: "Pasithea Therapeutics Corp."
filed_at: "2026-02-20T23:59:59+00:00"
generated_at: "2026-05-16T01:32:11.275345+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Pasithea receives Nasdaq bid price deficiency notice; 180-day cure period

## Summary
- Received Nasdaq notice on Feb 20, 2026 for failing minimum $1.00 bid price for 30 consecutive business days.
- Company has until August 19, 2026 to regain compliance; needs closing bid >=$1.00 for 10 consecutive days.
- If not cured, may qualify for additional 180 days if it meets other listing standards and considers reverse split.
- Notice does not affect business operations or SEC reporting; company evaluating options to regain compliance.

## SEC filing metadata
- accession: 0001213900-26-018874
- form_type: 8-K
- ticker: KTTA
- cik: 0001841330
- company_name: Pasithea Therapeutics Corp.
- filed_at: 2026-02-20T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1841330/000121390026018874/0001213900-26-018874-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1841330/000121390026018874/ea0277843-8k_pasithea.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-26-018874
- JSON: https://secwatch.observer/filing/0001213900-26-018874.json
- Plain text: https://secwatch.observer/filing/0001213900-26-018874.txt

## Source-grounded claims
- claim_id: d57146d39811bc204fe6f86f046a625ee7da30ca
  claim: Pasithea Therapeutics Corp. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2)).
  evidence_excerpt: February 20, 2026, Pasithea Therapeutics Corp. (the “Company”) received a written notice (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market (“Nasdaq”) indicating that the Company is not in compliance with the $1.00 minimum bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2) for continued listing on The Nasdaq Capital Market (the “Bid Price Requirement”). The Notice does not result in the immediate delisting of the Company’s common stock from The Nasdaq Capital Market. The Nasdaq Listing Rules require listed securities to maintain a minimum bid pr
  evidence_url: https://www.sec.gov/Archives/edgar/data/1841330/000121390026018874/0001213900-26-018874-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.